From the 28th Annual San Antonio Breast Cancer Symposium - into clinical practice: What does it mean for our patients?WOLMARK, Norman.European journal of cancer. Supplement (1990). 2006, Vol 4, Num 5, issn 1359-6349, 26 p.Serial Issue

Managing chemotherapy toxicity issuesDONOVAN, Gill.European journal of cancer. Supplement (1990). 2006, Vol 4, Num 5, pp 18-20, issn 1359-6349, 3 p.Article

CALGB 9344/CALGB C9741 : what have we learned?HUDIS, Clifford.European journal of cancer. Supplement (1990). 2006, Vol 4, Num 5, pp 10-12, issn 1359-6349, 3 p.Article

Docetaxel and trastuzumab in the adjuvant setting : translating SABCS into clinical practiceEIERMANN, Wolfgang.European journal of cancer. Supplement (1990). 2006, Vol 4, Num 5, pp 5-9, issn 1359-6349, 5 p.Article

Docetaxel versus paclitaxel in the adjuvant setting : translating SABCS into clinical practiceRAVDIN, Peter.European journal of cancer. Supplement (1990). 2006, Vol 4, Num 5, pp 13-17, issn 1359-6349, 5 p.Article

Maximising outcomes in adjuvant breast cancerCROWN, John.European journal of cancer. Supplement (1990). 2006, Vol 4, Num 5, pp 21-24, issn 1359-6349, 4 p.Article

Five versus more than five years of tamoxifen for lymph node-negative breast cancer: Updated findings from the National Surgical Adjuvant Breast and Bowel project B-14 randomized trialFISHER, Bernard; DIGNAM, James; BRYANT, John et al.Journal of the National Cancer Institute. 2001, Vol 93, Num 9, pp 684-690, issn 0027-8874Article

National Surgical Adjuvant Breast and Bowel Project trials in colon cancerWOLMARK, Norman; COLANGELO, Linda; WIEAND, Sam et al.Seminars in oncology. 2001, Vol 28, Num 1, pp 9-13, issn 0093-7754, SUP1Conference Paper

Sentinel node biopsy after neoadjuvant chemotherapy for breast cancerJULIAN, Thomas B; DUSI, Deborah; WOLMARK, Norman et al.The American journal of surgery. 2002, Vol 184, Num 4, pp 315-317, issn 0002-9610Conference Paper

Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: Updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trialsFISHER, Bernard; JEONG, Jong-Hyeon; ANDERSON, Stewart et al.Journal of the National Cancer Institute. 2004, Vol 96, Num 24, pp 1823-1831, issn 0027-8874, 9 p.Article

The incidence of lung carcinoma after surgery for Breast carcinoma with and without postoperative radiotherapy: Results of National Surgical Adjuvant Breast and bowel Project (NSABP) clinical trials B-04 and B-06DEUTSCH, Melvin; LAND, Stephanie R; BEGOVIC, Mirsada et al.Cancer. 2003, Vol 98, Num 7, pp 1362-1368, issn 0008-543X, 7 p.Article

Role of Anthracyclines in the Treatment of Early Breast CancerGIANNI, Luca; NORTON, Larry; WOLMARK, Norman et al.Journal of clinical oncology. 2009, Vol 27, Num 28, pp 4798-4808, issn 0732-183X, 11 p.Article

Fifteen-year prognostic discriminants for invasive Breast carcinoma: National Surgical adjuvant Breast and Bowel Project protocol-06FISHER, Edwin R; ANDERSON, Stewart; TAN-CHIU, Elizabeth et al.Cancer. 2001, Vol 91, Num 8, pp 1679-1687, issn 0008-543X, SUPConference Paper

Randomized trial of Adjuvant therapy in colon carcinoma: 10-Year results of NSABP protocol C-01SMITH, Roy E; COLANGELO, Linda; WIEAND, H. Samuel et al.Journal of the National Cancer Institute. 2004, Vol 96, Num 15, pp 1128-1132, issn 0027-8874, 5 p.Article

Pathobiology of preoperative chemotherapy: Findings from the National Surgical Adjuvant Breast and bowel Project (NSABP) protocol B-18FISHER, Edwin R; JIPING WANG; BRYANT, John et al.Cancer. 2002, Vol 95, Num 4, pp 681-695, issn 0008-543XArticle

Pathologic findings from the national surgical adjuvant breast and bowel project: Twelve-year observations concerning lobular carcinoma in situFISHER, Edwin R; LAND, Stephanie R; FISHER, Bernard et al.Cancer. 2004, Vol 100, Num 2, pp 238-244, issn 0008-543X, 7 p.Article

Lack of influence of cytokeratin-positive mini micrometastases in negative node patients with colorectal cancer: Findings from the National Surgical Adjuvant Breast and Bowel Projects Protocols R-01 and C-01. CommentaryFISHER, Edwin R; COLANGELO, Linda; WIEAND, Samuel et al.Diseases of the colon & rectum. 2003, Vol 46, Num 8, pp 1021-1026, issn 0012-3706, 6 p.Article

Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the national surgical adjuvant breast and bowel project experienceFISHER, Bernard; LAND, Stephanie; MAMOUNAS, Eleftherios et al.Seminars in oncology. 2001, Vol 28, Num 4, pp 400-418, issn 0093-7754Article

Twenty-five-year follow-up of A randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiationFISHER, Bernard; JEONG, Jong-Hyeon; ANDERSON, Stewart et al.The New England journal of medicine. 2002, Vol 347, Num 8, pp 567-575, issn 0028-4793Article

Defective Mismatch Repair and Benefit from Bevacizumab for Colon Cancer: Findings from NSABP C-08POGUE-GEILE, Kay; YOTHERS, Greg; ALLEGRA, Carmen et al.Journal of the National Cancer Institute. 2013, Vol 105, Num 13, pp 989-992, issn 0027-8874, 4 p.Article

Validation of the 12-Gene Colon Cancer Recurrence Score in NSABP C-07 As a Predictor of Recurrence in Patients With Stage II and III Colon Cancer Treated With Fluorouracil and Leucovorin (FU/LV) and FU/LV Plus OxaliplatinYOTHERS, Greg; O'CONNELL, Michael J; LEE, Mark et al.Journal of clinical oncology. 2013, Vol 31, Num 36, pp 4512-4519, issn 0732-183X, 8 p.Article

Primary mFOLFOX6 Plus Bevacizumab Without Resection of the Primary Tumor for Patients Presenting With Surgically Unresectable Metastatic Colon Cancer and an Intact Asymptomatic Colon Cancer: Definitive Analysis of NSABP Trial C-10MCCAHILL, Laurence E; YOTHERS, Greg; WAGMAN, Lawrence D et al.Journal of clinical oncology. 2012, Vol 30, Num 26, pp 3223-3228, issn 0732-183X, 6 p.Article

Risk of Recurrence and Chemotherapy Benefit for Patients With Node-Negative, Estrogen Receptor-Positive Breast Cancer: Recurrence Score Alone and Integrated With Pathologic and Clinical FactorsGONG TANG; CUZICK, Jack; COSTANTINO, Joseph P et al.Journal of clinical oncology. 2011, Vol 29, Num 33, pp 4365-4372, issn 0732-183X, 8 p.Article

Preoperative Multimodality Therapy Improves Disease-Free Survival in Patients With Carcinoma of the Rectum: NSABP R-03ROH, Mark S; COLANGELO, Linda H; WOLMARK, Norman et al.Journal of clinical oncology. 2009, Vol 27, Num 31, pp 5124-5130, issn 0732-183X, 7 p.Article

Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: Results from NSABP C-07KUEBLER, J. Philip; WIEAND, H. Samuel; ZAPAS, John L et al.Journal of clinical oncology. 2007, Vol 25, Num 16, pp 2198-2204, issn 0732-183X, 7 p.Article